Publication | Closed Access

Human serum albumin reduces the potency of acetylcholinesterase inhibitor based drugs for Alzheimer's disease

Alzheimer's DiseaseAcetylcholinesterase InhibitorMedicineDementiaVascular DementiaNeuropharmacologyNeurochemical BiomarkersHuman Serum AlbuminNeurologyNeuroscienceNeurodegenerationAging-associated DiseasePharmacologyLewy Body Dementia